& Kalaitzakis, E
Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, et al
Acknowledgements The National Natural Science Foundation of China (NSFC) (grant number 82171575) and the Hubei Provincial Clinical Medical Research Center for Nephropathy (grant number OIR202402Z) were gratefully acknowledged
By reducing appetite and increasing feelings of fullness, semaglutide can help patients achieve sustainable weight loss
Any trend toward higher fasting glucose or declining insulin sensitivity should trigger protocol reassessment
In this issue, were diving deeper into the potential benefits of GLP-1 agonist medicationswidely known for treating diabetes and weight managementon neurological, cardiovascular, and immune system health